Gene · 8434
Papers1,933
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 1,933
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Simultaneous Targeting of Multiple oncomiRs with Phosphorothioate or PNA-Based Anti-miRs in Lymphoma Cell Lines. | Pharm Res | 2022 | 36071352 | PubTator, text mining | PubMed |
| Nasal Staphylococcus aureus and S. pseudintermedius carriage in healthy dogs and cats: a systematic review of their antibiotic resistance, virulence and genetic lineages of zoonotic relevance. | J Appl Microbiol | 2022 | 36063061 | PubTator, text mining | PubMed |
| Role of endometrial microRNAs in repeated implantation failure (mini-review). | Front Cell Dev Biol | 2022 | 36060804 | PubTator, text mining | PubMed |
| Comparative Analysis of Clinical and Genomic Characteristics of Hypervirulent Klebsiella pneumoniae from Hospital and Community Settings: Experience from a Tertiary Healthcare Center in India. | Microbiol Spectr | 2022 | 36043878 | PubTator, text mining | PubMed |
| Landscape of the epigenetic regulation in wound healing. | Front Physiol | 2022 | 36035490 | PubTator, text mining | PubMed |
| Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis. | Front Pharmacol | 2022 | 36034858 | PubTator, text mining | PubMed |
| Potential molecular mechanism in self-renewal is associated with miRNA dysregulation in sacral chordoma - A next-generation RNA sequencing study. | Heliyon | 2022 | 36033338 | PubTator, text mining | PubMed |
| Current Opportunities for Targeting Dysregulated Neurodevelopmental Signaling Pathways in Glioblastoma. | Cells | 2022 | 36010607 | PubTator, text mining | PubMed |
| Anti-migratory effect of curcumin on A-549 lung cancer cells via epigenetic reprogramming of RECK/ matrix metalloproteinase axis. | Horm Mol Biol Clin Investig | 2022 | 35993840 | PubTator, text mining | PubMed |
| Predictability of parental ultraviolet-B environment shapes the growth strategies of clonal Glechoma longituba. | Front Plant Sci | 2022 | 35991455 | PubTator, text mining | PubMed |
| Large-scale transcriptomic analysis of coding and non-coding pathological biomarkers, associated with the tumor immune microenvironment of thyroid cancer and potential target therapy exploration. | Front Cell Dev Biol | 2022 | 35990603 | PubTator, text mining | PubMed |
| The Inhibitory Effect on Tumor Cells Proliferation Induced by Arsenic Through DNMTs and its Downstream Molecules: A Systematic Review and Meta-Analysis. | Curr Pharm Des | 2022 | 35984018 | PubTator, text mining | PubMed |
| Investigating melanogenesis-related microRNAs as disease biomarkers in vitiligo. | Sci Rep | 2022 | 35941163 | PubTator, text mining | PubMed |
| RECK gene polymorphisms in hepatitis B-related hepatocellular carcinoma: A case-control study. | Arab J Gastroenterol | 2022 | 35941073 | PubTator, text mining | PubMed |
| The Key Role of microRNAs in Initiation and Progression of Hepatocellular Carcinoma. | Front Oncol | 2022 | 35924150 | PubTator, text mining | PubMed |
| Recent insights into the microRNA-dependent modulation of gliomas from pathogenesis to diagnosis and treatment. | Cell Mol Biol Lett | 2022 | 35922753 | PubTator, text mining | PubMed |
| Combined comparative genomics and clinical modeling reveals plasmid-encoded genes are independently associated with Klebsiella infection. | Nat Commun | 2022 | 35915063 | PubTator, text mining | PubMed |
| Role of exosomal microRNAs in cancer therapy and drug resistance mechanisms: focus on hepatocellular carcinoma. | Front Oncol | 2022 | 35912267 | PubTator, text mining | PubMed |
| Non-Coding RNAs and Oral Cancer: Small Molecules With Big Functions. | Front Oncol | 2022 | 35898889 | PubTator, text mining | PubMed |
| Comprehensive Analyses of miRNAs Revealed miR-92b-3p, miR-182-5p and miR-183-5p as Potential Novel Biomarkers in Melanoma-Derived Extracellular Vesicles. | Front Oncol | 2022 | 35898875 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8434/papers?page=14